Implicator
Munich-based Marvel Fusion GmbH told investors it plans to sell its laser technology for defense, medical, and industrial uses, Bloomberg reported Tuesday. The billion-dollar fusion startup needs revenue while its core technology, a nuclear fusion power plant, remains years from commercial reality. Executives also told investors the company may relocate its headquarters from Germany to the United States to improve access to capital.
More than $10 billion flowed into fusion startups in the past few years, according to TechCrunch, and a dozen of those companies pulled in upwards of $100 million apiece. Most of them face the same problem. Physics moves slowly. Investors want returns. And the defense sector, with its appetite for new laser weapons, has money to spend today, not in a decade. The DIW, Germany's economic research institute, noticed the pattern. Fusion companies are selling magnets and specialty materials on the side. They are not waiting for a reactor that works. They cannot afford to.
Maria Garcia
Bilingual tech journalist slicing through AI noise at implicator.ai. Decodes digital culture with a ruthless Gen Z lens—fast, sharp, relentlessly curious. Bridges Silicon Valley's marble boardrooms, hunting who tech really serves.
